The CDC Says Child Flu Deaths Reached Concerning Highs Last Year
The CDC just released data that show a lot of children died of the flu last year. Here's what doctors recommend.
WUWM1d
No needles required: The FDA approves an at-home flu vaccine
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
GlobalData on MSN2d
Mpox: Three ongoing vaccine trials to watch
As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing vaccine trials.
France 2411d
Moderna mRNA mpox vaccine shows promise in animal study
An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...
infectiousdiseaseadvisor.com4d
Chikungunya Vaccine Is Safe, Effective, and Provides High Protection at 2 Years
A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.
When is the best time to get your flu shot?
Flu season is approaching in the United States. Here's what you can expect this year — and when to get your flu vaccine to ...
MPox: First Batch Of Shots Reaches Congo, But How Much Of Help Is It? The Trickle-Down Vaccine Economy
The European Union donated the 100,000 doses of the JYNNEOS vaccine, manufactured by the Danish company Bavarian Nordic.
The EMBO Journal1d
TBK1-Zyxin signaling controls tumor-associated macrophage recruitment to mitigate antitumor immunity
Although the role of innate immune sensing pathways is well-studied in the pathogenesis of malignancies, whether they ...
New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
DAYBREAK was a Phase 3, multi-center, long-term open-label extension study to evaluate the safety and efficacy of Zeposia (ozanimod) administered orally to patients with relapsing forms of multiple ...